Detalhe da pesquisa
1.
Improving equity in kidney transplant allocation policies through a novel genetic metric: The Matched Donor Potential.
Am J Transplant
; 23(1): 45-54, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36695620
2.
Restriction of interleukin-6 alters endothelial cell immunogenicity in an allogenic environment.
Clin Transplant
; 37(3): e14851, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36495142
3.
[Medication adherence in renal transplantation: Evaluation, predictive factors and impact on humoral alloreactivity]. / Adhésion médicamenteuse en greffe rénale : évaluation, facteurs prédictifs et impact sur l'allo-réactivité humorale.
Ann Pharm Fr
; 81(1): 152-162, 2023 Jan.
Artigo
em Francês
| MEDLINE | ID: mdl-35792151
4.
Restriction of interleukin-6 alters endothelial cell immunogenicity in an allogenic environment.
Clin Transplant
; 36(12): e14815, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36114597
5.
Surrogate Endpoints for Late Kidney Transplantation Failure.
Transpl Int
; 35: 10136, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35669974
6.
Proposed Definitions of T Cell-Mediated Rejection and Tubulointerstitial Inflammation as Clinical Trial Endpoints in Kidney Transplantation.
Transpl Int
; 35: 10135, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35669975
7.
Proposed Definitions of Antibody-Mediated Rejection for Use as a Clinical Trial Endpoint in Kidney Transplantation.
Transpl Int
; 35: 10140, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35669973
8.
Rationale for Surrogate Endpoints and Conditional Marketing Authorization of New Therapies for Kidney Transplantation.
Transpl Int
; 35: 10137, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35669977
9.
Assessment of the Utility of Kidney Histology as a Basis for Discarding Organs in the United States: A Comparison of International Transplant Practices and Outcomes.
J Am Soc Nephrol
; 32(2): 397-409, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33323474
10.
Trajectories of glomerular filtration rate and progression to end stage kidney disease after kidney transplantation.
Kidney Int
; 99(1): 186-197, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32781106
11.
Living kidney donor evaluation for all candidates with normal estimated GFR for age.
Transpl Int
; 34(6): 1123-1133, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33774875
12.
COVID-19 Infection in Kidney Transplant Recipients: Disease Incidence and Clinical Outcomes.
J Am Soc Nephrol
; 31(10): 2413-2423, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32847984
13.
The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell- and antibody-mediated rejection.
Am J Transplant
; 20(9): 2318-2331, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32463180
14.
Comparison of machine perfusion versus cold storage in kidney transplant recipients from expanded criteria donors: a cohort-based study.
Nephrol Dial Transplant
; 35(6): 1043-1070, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32516809
15.
The weekend effect in kidney transplantation outcomes: a French cohort-based study.
Transpl Int
; 33(9): 1030-1039, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32428980
16.
Archetype Analysis Identifies Distinct Profiles in Renal Transplant Recipients with Transplant Glomerulopathy Associated with Allograft Survival.
J Am Soc Nephrol
; 30(4): 625-639, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30872323
17.
HLA-DQ alloantibodies directly activate the endothelium and compromise differentiation of FoxP3high regulatory T lymphocytes.
Kidney Int
; 96(3): 689-698, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31307777
18.
Non-HLA agonistic anti-angiotensin II type 1 receptor antibodies induce a distinctive phenotype of antibody-mediated rejection in kidney transplant recipients.
Kidney Int
; 96(1): 189-201, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31005275
19.
Response to treatment and long-term outcomes in kidney transplant recipients with acute T cell-mediated rejection.
Am J Transplant
; 19(7): 1972-1988, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30748089
20.
Safety and efficacy of eculizumab in the prevention of antibody-mediated rejection in living-donor kidney transplant recipients requiring desensitization therapy: A randomized trial.
Am J Transplant
; 19(10): 2876-2888, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30887675